{"id":"W4416017497","doi":"10.1016/j.lungcan.2025.108834","title":"MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Durvalumab; Chemotherapy; Lung cancer; Disease; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001225539,0.000365576,0.0006292503,0.0001943435,0.00008766435,0.00005546125,0.00007748041,0.00008963796,0.0002274386],"category_scores_gemma":[0.000002993572,0.0002667961,0.00006725515,0.000385824,0.0001570864,0.00007179462,0.00002398848,0.0001729187,6.214011e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000934607,"about_ca_system_score_gemma":0.0007475236,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01053021,"about_ca_topic_score_gemma":0.008200501,"domain_scores_codex":[0.9985496,0.00004294755,0.0002740668,0.0005443034,0.000179633,0.0004094803],"domain_scores_gemma":[0.9993782,0.00003661714,0.0001130857,0.0003065473,0.0000544675,0.0001110664],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01485049,0.0004079763,0.8411906,0.002251718,0.002990565,0.0001062936,0.008132141,0.00009172468,0.01935464,0.00001574396,0.002190107,0.108418],"study_design_scores_gemma":[0.1735264,0.002505982,0.7131205,0.007163914,0.004584388,0.0001418249,0.00300062,0.0322195,0.04372584,0.00004558003,0.01804438,0.001921134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9511831,0.04273826,0.0001530935,0.002292482,0.0001981866,0.001505234,0.00003872513,0.0000435146,0.001847441],"genre_scores_gemma":[0.9644739,0.0208052,0.0006893257,0.001890558,0.00009973715,0.0005923359,0.00001539863,0.00006367453,0.01136984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1586759,"threshold_uncertainty_score":0.9999784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009759950064900491,"score_gpt":0.3044476110311205,"score_spread":0.29468766096622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}